文献速递临床试验与 GCP真实世界研究与卫生经济

跨医疗部门使用患者报告结局(C-PRO)对慢性退行性肩部疾病患者每单位生活质量改善成本的影响——一项随机对照试验的研究方案

Cross-sectoral use of Patient-Reported Outcomes (C-PRO)-the effect on the cost per improvement in quality of life for patients with chronic degenerative shoulder conditions-a protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2025-12-12

本研究为随机对照试验,纳入慢性退行性肩部疾病患者,干预组患者及治疗方均可查看患者报告结局(PRO)数据,对照组数据仅收集不开放。比较两组医疗资源使用及成本效果(每单位生活质量改善成本),并评估满意度。

要点

  • 干预组患者及治疗方共享PRO数据,对照组数据不开放。
  • 主要结局为每单位生活质量改善的成本及医疗资源使用。
  • 计划纳入开始日期为2024年8月12日。

核心结论

  • 系统性使用PRO可能帮助患者和临床医生了解治疗期间的症狀发展,并优化个体治疗及医疗资源使用。

研究设计与样本

  • 随机对照试验,纳入期1年,随访期2年;纳入慢性退行性肩部疾病患者(肩盂肱关节撞击/肩锁关节疼痛、盂肱关节骨关节炎、肩袖退变或冻结肩)。

主要发现

  • 每2个月要求患者完成肩部功能(牛津肩部评分)、生活质量(EQ-5D-5L)及试验特异性问卷。
  • 前瞻性登记随访期间在全科医生、骨科及市政理疗中心的医疗接触。
  • 试验结束后从丹麦国家登记处收集2年随访期间医疗服务使用数据,比较两组医疗服务使用及对肩部问题评估和治疗的满意度。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to investigate the effect of the systematic use of patient-reported outcomes (PROs) across healthcare sectors on treatment outcomes and cost-effectiveness (measured as cost per improvement in quality of life) in people with chronic degenerative shoulder conditions. METHODS: In this randomised controlled trial with a 1-year inclusion period and 2-year follow-up, patients with a degenerative shoulder condition (glenohumeral impingement/pain of the acromioclavicular joint, glenohumeral osteoarthritis, rotator cuff degeneration or frozen shoulder) will be included. Every 2nd month, they will be asked to complete questionnaires about the shoulder function (Oxford Shoulder Score), quality of life (EQ-5D-5L) and a trial-specific questionnaire. Healthcare contacts at the general practitioner (GP), the orthopaedic department and the municipal physiotherapeutic centres will be registered prospectively during the follow-up period. In the intervention group, all collected data will be available to the patient and any treating party (GP, orthopaedic surgeons and physiotherapists). For the control group, trial data will be collected, but neither patient nor healthcare professionals will have access to these. After trial termination, follow-up data on use of healthcare services during the 2-year follow-up time will be collected from the Danish National Registries and the intervention and the control group will be compared with regard to use of healthcare services and satisfaction with the evaluation and treatment of their shoulder problem. DISCUSSION: Systematic use of PROs may be a tool to provide patients and clinicians with an insight into symptom development during treatment and to optimise both the treatment of the individual patient as well as a smarter use of the resources available in the healthcare system. The inclusion of patients begins on the 12th of August 2024. TRIAL REGISTRATION: ClinicalTrials.gov NCT06435494. Registration date 16th of May 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Nyholm AM, Esbensen BA, Westergaard CL, et al. Cross-sectoral use of Patient-Reported Outcomes (C-PRO)-the effect on the cost per improvement in quality of life for patients with chronic degenerative shoulder conditions-a protocol for a randomised controlled trial. Trials. 2025. PMID: 41382298. doi:10.1186/s13063-025-09329-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。